It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNVVF’s FA Score shows that 1 FA rating(s) are green whileCSBTF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNVVF’s TA Score shows that 3 TA indicator(s) are bullish while CSBTF’s TA Score has 5 bullish TA indicator(s).
CNVVF (@Pharmaceuticals: Other) experienced а -10.61% price change this week, while CSBTF (@Medical/Nursing Services) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.62%. For the same industry, the average monthly price growth was +0.12%, and the average quarterly price growth was +6.19%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.41%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +6.50%.
CSBTF is expected to report earnings on Mar 10, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+0.41% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| CNVVF | CSBTF | CNVVF / CSBTF | |
| Capitalization | 6.1B | 1.32B | 463% |
| EBITDA | 567M | 3.16M | 17,960% |
| Gain YTD | -3.806 | 60.611 | -6% |
| P/E Ratio | 26.23 | N/A | - |
| Revenue | 2.36B | 103M | 2,287% |
| Total Cash | 95.7M | 17.9M | 535% |
| Total Debt | 1.34B | 1.79M | 74,819% |
CNVVF | CSBTF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 98 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | 53 Fair valued | |
PROFIT vs RISK RATING 1..100 | 75 | 19 | |
SMR RATING 1..100 | 85 | 93 | |
PRICE GROWTH RATING 1..100 | 63 | 48 | |
P/E GROWTH RATING 1..100 | 80 | 100 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CNVVF's Valuation (19) in the null industry is somewhat better than the same rating for CSBTF (53). This means that CNVVF’s stock grew somewhat faster than CSBTF’s over the last 12 months.
CSBTF's Profit vs Risk Rating (19) in the null industry is somewhat better than the same rating for CNVVF (75). This means that CSBTF’s stock grew somewhat faster than CNVVF’s over the last 12 months.
CNVVF's SMR Rating (85) in the null industry is in the same range as CSBTF (93). This means that CNVVF’s stock grew similarly to CSBTF’s over the last 12 months.
CSBTF's Price Growth Rating (48) in the null industry is in the same range as CNVVF (63). This means that CSBTF’s stock grew similarly to CNVVF’s over the last 12 months.
CNVVF's P/E Growth Rating (80) in the null industry is in the same range as CSBTF (100). This means that CNVVF’s stock grew similarly to CSBTF’s over the last 12 months.
| CNVVF | CSBTF | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 36% | 2 days ago 46% |
| Stochastic ODDS (%) | 2 days ago 30% | 2 days ago 70% |
| Momentum ODDS (%) | 2 days ago 19% | 2 days ago 71% |
| MACD ODDS (%) | 2 days ago 39% | 2 days ago 45% |
| TrendWeek ODDS (%) | 2 days ago 20% | 2 days ago 39% |
| TrendMonth ODDS (%) | 2 days ago 20% | 2 days ago 44% |
| Advances ODDS (%) | N/A | 29 days ago 81% |
| Declines ODDS (%) | N/A | 25 days ago 60% |
| BollingerBands ODDS (%) | 2 days ago 50% | N/A |
| Aroon ODDS (%) | N/A | 2 days ago 72% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DILYX | 16.66 | 0.10 | +0.60% |
| Davis International Y | |||
| RDWAX | 13.93 | 0.07 | +0.51% |
| American Funds Dvlpg Wld Gr&Inc R1 | |||
| FTHSX | 49.43 | 0.17 | +0.35% |
| FullerThaler Behavioral Sm-Cp Eq Inst | |||
| FBOGX | 9.91 | 0.03 | +0.30% |
| Templeton Global Smaller Comp R6 | |||
| NGJFX | 19.33 | -0.08 | -0.41% |
| Nuveen Global Real Estate Securities R6 | |||
A.I.dvisor indicates that over the last year, CNVVF has been loosely correlated with FLMNY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNVVF jumps, then FLMNY could also see price increases.
| Ticker / NAME | Correlation To CNVVF | 1D Price Change % | ||
|---|---|---|---|---|
| CNVVF | 100% | N/A | ||
| FLMNY - CNVVF | 36% Loosely correlated | N/A | ||
| SAFLY - CNVVF | 32% Poorly correlated | N/A | ||
| GKOS - CNVVF | 24% Poorly correlated | +3.03% | ||
| EW - CNVVF | 23% Poorly correlated | +0.49% | ||
| OFIX - CNVVF | 22% Poorly correlated | -0.52% | ||
More | ||||
A.I.dvisor tells us that CSBTF and APYX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBTF and APYX's prices will move in lockstep.
| Ticker / NAME | Correlation To CSBTF | 1D Price Change % | ||
|---|---|---|---|---|
| CSBTF | 100% | N/A | ||
| APYX - CSBTF | 22% Poorly correlated | +8.25% | ||
| DIZTF - CSBTF | 4% Poorly correlated | N/A | ||
| CHEOY - CSBTF | 2% Poorly correlated | -0.69% | ||
| CLPBF - CSBTF | 2% Poorly correlated | +3.98% | ||
| CNVVF - CSBTF | 1% Poorly correlated | N/A | ||
More | ||||